These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 10768972

  • 1. Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection.
    Weltzin R, Guy B, Thomas WD, Giannasca PJ, Monath TP.
    Infect Immun; 2000 May; 68(5):2775-82. PubMed ID: 10768972
    [Abstract] [Full Text] [Related]

  • 2. A double mutant heat-labile toxin from Escherichia coli, LT(R192G/L211A), is an effective mucosal adjuvant for vaccination against Helicobacter pylori infection.
    Sjökvist Ottsjö L, Flach CF, Clements J, Holmgren J, Raghavan S.
    Infect Immun; 2013 May; 81(5):1532-40. PubMed ID: 23439305
    [Abstract] [Full Text] [Related]

  • 3. Oral immunization with recombinant Helicobacter pylori urease confers long-lasting immunity against Helicobacter felis infection.
    Myers GA, Ermak TH, Georgakopoulos K, Tibbitts T, Ingrassia J, Gray H, Kleanthous H, Lee CK, Monath TP.
    Vaccine; 1999 Mar 17; 17(11-12):1394-403. PubMed ID: 10195775
    [Abstract] [Full Text] [Related]

  • 4. The mucosal adjuvanticity of two nontoxic mutants of Escherichia coli heat-labile enterotoxin varies with immunization routes.
    Park EJ, Chang JH, Kim JS, Yum JS, Chung SI.
    Exp Mol Med; 2000 Jun 30; 32(2):72-8. PubMed ID: 10926118
    [Abstract] [Full Text] [Related]

  • 5. Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection.
    Weltzin R, Kleanthous H, Guirakhoo F, Monath TP, Lee CK.
    Vaccine; 1997 Mar 30; 15(4):370-6. PubMed ID: 9141207
    [Abstract] [Full Text] [Related]

  • 6. Safety and efficacy of E coli enterotoxin adjuvant for urease-based rectal immunization against Helicobacter pylori.
    Sougioultzis S, Lee CK, Alsahli M, Banerjee S, Cadoz M, Schrader R, Guy B, Bedford P, Monath TP, Kelly CP, Michetti P.
    Vaccine; 2002 Dec 13; 21(3-4):194-201. PubMed ID: 12450694
    [Abstract] [Full Text] [Related]

  • 7. [Immunopotency of the recombinant urease B subunit vaccine of Helicobacter pylori after intranasal administration to mice].
    Gao ZG, Zou QM, Guo G, Guo TS, Zou QM, Zeng WK, Xie QH.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan 13; 19(1):68-70. PubMed ID: 15132912
    [Abstract] [Full Text] [Related]

  • 8. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults.
    Michetti P, Kreiss C, Kotloff KL, Porta N, Blanco JL, Bachmann D, Herranz M, Saldinger PF, Corthésy-Theulaz I, Losonsky G, Nichols R, Simon J, Stolte M, Ackerman S, Monath TP, Blum AL.
    Gastroenterology; 1999 Apr 13; 116(4):804-12. PubMed ID: 10092302
    [Abstract] [Full Text] [Related]

  • 9. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses.
    Ermak TH, Giannasca PJ, Nichols R, Myers GA, Nedrud J, Weltzin R, Lee CK, Kleanthous H, Monath TP.
    J Exp Med; 1998 Dec 21; 188(12):2277-88. PubMed ID: 9858514
    [Abstract] [Full Text] [Related]

  • 10. Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant.
    Marchetti M, Rossi M, Giannelli V, Giuliani MM, Pizza M, Censini S, Covacci A, Massari P, Pagliaccia C, Manetti R, Telford JL, Douce G, Dougan G, Rappuoli R, Ghiara P.
    Vaccine; 1998 Jan 21; 16(1):33-7. PubMed ID: 9607006
    [Abstract] [Full Text] [Related]

  • 11. Vaccination against Helicobacter pylori in non-human primate models and humans.
    Lee CK.
    Scand J Immunol; 2001 May 21; 53(5):437-42. PubMed ID: 11309150
    [Abstract] [Full Text] [Related]

  • 12. Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys.
    Lee CK, Soike K, Hill J, Georgakopoulos K, Tibbitts T, Ingrassia J, Gray H, Boden J, Kleanthous H, Giannasca P, Ermak T, Weltzin R, Blanchard J, Monath TP.
    Vaccine; 1999 Mar 17; 17(11-12):1493-505. PubMed ID: 10195786
    [Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of low dose Escherichia coli enterotoxin adjuvant for urease based oral immunisation against Helicobacter pylori in healthy volunteers.
    Banerjee S, Medina-Fatimi A, Nichols R, Tendler D, Michetti M, Simon J, Kelly CP, Monath TP, Michetti P.
    Gut; 2002 Nov 17; 51(5):634-40. PubMed ID: 12377799
    [Abstract] [Full Text] [Related]

  • 14. Immunization against natural Helicobacter pylori infection in nonhuman primates.
    Dubois A, Lee CK, Fiala N, Kleanthous H, Mehlman PT, Monath T.
    Infect Immun; 1998 Sep 17; 66(9):4340-6. PubMed ID: 9712786
    [Abstract] [Full Text] [Related]

  • 15. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis.
    Lee CK, Weltzin R, Thomas WD, Kleanthous H, Ermak TH, Soman G, Hill JE, Ackerman SK, Monath TP.
    J Infect Dis; 1995 Jul 17; 172(1):161-72. PubMed ID: 7797906
    [Abstract] [Full Text] [Related]

  • 16. Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection.
    Kotloff KL, Sztein MB, Wasserman SS, Losonsky GA, DiLorenzo SC, Walker RI.
    Infect Immun; 2001 Jun 17; 69(6):3581-90. PubMed ID: 11349017
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection.
    Kleanthous H, Myers GA, Georgakopoulos KM, Tibbitts TJ, Ingrassia JW, Gray HL, Ding R, Zhang ZZ, Lei W, Nichols R, Lee CK, Ermak TH, Monath TP.
    Infect Immun; 1998 Jun 17; 66(6):2879-86. PubMed ID: 9596763
    [Abstract] [Full Text] [Related]

  • 19. Immunization of rhesus monkeys with a mucosal prime, parenteral boost strategy protects against infection with Helicobacter pylori.
    Lee CK, Soike K, Giannasca P, Hill J, Weltzin R, Kleanthous H, Blanchard J, Monath TP.
    Vaccine; 1999 Aug 06; 17(23-24):3072-82. PubMed ID: 10462242
    [Abstract] [Full Text] [Related]

  • 20. Toward the development of a stable, freeze-dried formulation of Helicobacter pylori killed whole cell vaccine adjuvanted with a novel mutant of Escherichia coli heat-labile toxin.
    Summerton NA, Welch RW, Bondoc L, Yang HH, Pleune B, Ramachandran N, Harris AM, Bland D, Jackson WJ, Park S, Clements JD, Nabors GS.
    Vaccine; 2010 Feb 03; 28(5):1404-11. PubMed ID: 19897067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.